{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T05:54:39Z","timestamp":1790747679578,"version":"4.1.0"},"reference-count":86,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T00:00:00Z","timestamp":1790726400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Pancreatic cancer and type 2 diabetes mellitus (T2DM) are closely linked through complex epidemiological and biological interactions. However, the development, knowledge structure, and research trends of this field have not been systematically characterized. This study aimed to investigate the research landscape and knowledge structure of pancreatic cancer and T2DM research from 2006 to 2025.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted the primary bibliometric analysis using WOSCC records, and separately analyzed PubMed-indexed clinical trials as a supplementary dataset. A total of 1,989 WOSCC publications were included in the bibliometric analysis, while 54 PubMed-indexed Clinical Trial records were included in the supplementary clinical trial assessment. CiteSpace was used to perform collaboration, co-citation, keyword, timeline, and burst analyses of the WOSCC dataset.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The number of publications increased steadily over the study period, particularly after 2015. The United States and China were the leading contributors, while the University of California System and Harvard University were among the most productive institutions. Major research themes included cancer risk, insulin resistance, metabolic inflammation, incretin-based therapies, and new-onset diabetes. Keyword evolution and burst analyses indicated increasing attention to mechanistic investigation, biomarker discovery, risk stratification, and precision medicine approaches.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This study characterizes the development and knowledge structure of research on the relationship between pancreatic cancer and T2DM and highlights major research themes, emerging hotspots, and future directions for mechanistic investigation and clinical translation.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fendo.2026.1945735","type":"journal-article","created":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T04:55:59Z","timestamp":1790744159000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Research trends and knowledge structure of pancreatic cancer and type 2 diabetes mellitus research: a two-decade CiteSpace analysis"],"prefix":"10.3389","volume":"17","author":[{"given":"Zilin","family":"Dong","sequence":"first","affiliation":[{"name":"Acupuncture and Tuina School, Chengdu University of Traditional Chinese Medicine","place":["Chengdu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingting","family":"Zhou","sequence":"additional","affiliation":[{"name":"School of Clinical Medicine, Chengdu University of Traditional Chinese Medicine","place":["Chengdu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengwei","family":"Ma","sequence":"additional","affiliation":[{"name":"Acupuncture and Tuina School, Chengdu University of Traditional Chinese Medicine","place":["Chengdu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuannan","family":"Chen","sequence":"additional","affiliation":[{"name":"Acupuncture and Tuina School, Chengdu University of Traditional Chinese Medicine","place":["Chengdu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Lai","sequence":"additional","affiliation":[{"name":"School of Basic Medicine, Chengdu University of Traditional Chinese Medicine","place":["Chengdu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,9,30]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/s2468-1253(23)00366-7","article-title":"Global, regional, and national lifetime risks of developing and dying from gastrointestinal cancers in 185 countries: a population-based systematic analysis of GLOBOCAN","volume":"9","author":"Wang","year":"2024","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/dyu240","article-title":"Risk factors for pancreatic cancer: a summary review of meta-analytical studies","volume":"44","author":"Maisonneuve","year":"2015","journal-title":"Int J Epidemiol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1007\/bf00403322","article-title":"Islet amyloid polypeptide in diabetic and non-diabetic Pima Indians","volume":"33","author":"Clark","year":"1990","journal-title":"Diabetologia"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.2337\/diabetes.52.1.102","article-title":"Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes","volume":"52","author":"Butler","year":"2003","journal-title":"Diabetes"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.15.1869","article-title":"Clinical implications of fatty pancreas: correlations between fatty pancreas and metabolic syndrome","volume":"15","author":"Lee","year":"2009","journal-title":"World J Gastroenterol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"2941","DOI":"10.1038\/s41467-018-04951-w","article-title":"Genome-wide association analyses identify 143 risk variants and putative regulatory mechanisms for type 2 diabetes","volume":"9","author":"Xue","year":"2018","journal-title":"Nat Commun"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1097\/00006254-200203000-00018","article-title":"Diet, lifestyle, and the risk of type 2 diabetes mellitus in women","volume":"345","author":"Hu","year":"2001","journal-title":"N Engl J Med"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.30599","article-title":"Diabetes, plasma glucose and incidence of pancreatic cancer: A prospective study of 0.5 million Chinese adults and a meta-analysis of 22 cohort studies","volume":"140","author":"Pang","year":"2017","journal-title":"Int J Cancer"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.187424","article-title":"Type 2 diabetes alters quiescent pancreatic stellate cells to tumor-prone state","volume":"10","author":"Hara","year":"2025","journal-title":"JCI Insight"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2023.10.003","article-title":"Hyperinsulinemia acts via acinar insulin receptors to initiate pancreatic cancer by increasing digestive enzyme production and inflammation","volume":"35","author":"Zhang","year":"2023","journal-title":"Cell Metab"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.2337\/db16-1477","article-title":"Diabetes, pancreatogenic diabetes, and pancreatic cancer","volume":"66","author":"Andersen","year":"2017","journal-title":"Diabetes"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1007\/BF02016680","article-title":"Toward a definition of \u201cbibliometrics","volume":"12","author":"Broadus","year":"1987","journal-title":"Scientometrics"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1007\/s40037-021-00695-4","article-title":"Bibliometrics: Methods for studying academic publishing","volume":"11","author":"Ninkov","year":"2022","journal-title":"Perspect Med Educ"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0307513100","article-title":"Searching for intellectual turning points: progressive knowledge domain visualization","volume":"101","author":"Chen","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"key":"B15","article-title":"CiteSpace II: visualization and knowledge discovery in bibliographic databases","volume":"2005","author":"Synnestvedt","year":"2005","journal-title":"AMIA Annu Symp Proc"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1080\/0022250x.2001.9990249","article-title":"A faster algorithm for betweenness centrality","volume":"25","author":"Brandes","year":"2001","journal-title":"J Math Sociology"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/0378-8733(78)90021-7","article-title":"Centrality in social networks conceptual clarification","volume":"1","author":"Freeman","year":"1978","journal-title":"Soc Networks"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1002\/asi.20317","article-title":"CiteSpace II: detecting and visualizing emerging trends and transient patterns in scientific literature","volume":"57","author":"Chen","year":"2006","journal-title":"J Am Soc For Inf Sci Technol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.3727\/000000006783981675","article-title":"Tetracycline-regulated expression of VEGF-A in beta cells induces angiogenesis: improvement of engraftment following transplantation","volume":"15","author":"Mathe","year":"2006","journal-title":"Cell Transplant"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2011.02.018","article-title":"Pancreatitis, pancreatic, and thyroid cancer with glucagon-like peptide-1-based therapies","volume":"141","author":"Elashoff","year":"2011","journal-title":"Gastroenterology"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-009-1440-6","article-title":"The influence of glucose-lowering therapies on cancer risk in type 2 diabetes","volume":"52","author":"Currie","year":"2009","journal-title":"Diabetologia"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2009.04.013","article-title":"Antidiabetic therapies affect risk of pancreatic cancer","volume":"137","author":"Li","year":"2009","journal-title":"Gastroenterology"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2011.03.003","article-title":"Diabetes mellitus and risk of pancreatic cancer: a meta-analysis of cohort studies","volume":"47","author":"Ben","year":"2011","journal-title":"Eur J Cancer"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.3322\/caac.20078","article-title":"Diabetes and cancer: a consensus report","volume":"33","author":"Giovannucci","year":"2010","journal-title":"Diabetes Care"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.2337\/dc08-2175","article-title":"New users of metformin are at low risk of incident cancer: a cohort study among people with type 2 diabetes","volume":"32","author":"Libby","year":"2009","journal-title":"Diabetes Care"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21660","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.2337\/db12-1686","article-title":"Marked expansion of exocrine and endocrine pancreas with incretin therapy in humans with increased exocrine pancreas dysplasia and the potential for glucagon-producing neuroendocrine tumors","volume":"62","author":"Butler","year":"2013","journal-title":"Diabetes"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1056\/nejmoa1307684","article-title":"Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitus","volume":"369","author":"Scirica","year":"2013","journal-title":"N Engl J Med"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.2337\/dc12-0002","article-title":"Diabetes and cause-specific mortality in a prospective cohort of one million U.S. adults","volume":"35","author":"Campbell","year":"2012","journal-title":"Diabetes Care"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2025.06.025","article-title":"Risk of pancreatic cancer in glycemically defined new-onset diabetes: a prospective cohort study","volume":"170","author":"Chari","year":"2026","journal-title":"Gastroenterology"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2006.06.024","article-title":"New-onset diabetes and pancreatic cancer","volume":"4","author":"Gupta","year":"2006","journal-title":"Clin Gastroenterol Hepatol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/s10552-012-0078-8","article-title":"Diabetes and risk of pancreatic cancer: a pooled analysis from the pancreatic cancer cohort consortium","volume":"24","author":"Elena","year":"2013","journal-title":"Cancer Causes Control"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1016\/j.lanwpc.2022.100596","article-title":"Association between age at diabetes onset or diabetes duration and subsequent risk of pancreatic cancer: Results from a longitudinal cohort and mendelian randomization study","volume":"30","author":"Shen","year":"2023","journal-title":"Lancet Reg Health West Pac"},{"key":"B34","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1053\/j.gastro.2007.10.040","article-title":"Pancreatic cancer-associated diabetes mellitus: prevalence and temporal association with diagnosis of cancer","volume":"134","author":"Chari","year":"2008","journal-title":"Gastroenterology"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1097\/mpa.0000000000002257","article-title":"Association of long-term, new-onset, and postsurgical diabetes with survival in patients with resectable pancreatic cancer: a retrospective cohort study","volume":"52","author":"Kanbour","year":"2023","journal-title":"Pancreas"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1097\/as9.0000000000000584","article-title":"Prevalence of new-onset diabetes in patients undergoing pancreatic surgery and the association of glucose dysregulation with complications in pancreatic cancer","volume":"6","author":"Stott","year":"2025","journal-title":"Ann Surg Open"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1016\/j.pan.2023.07.001","article-title":"Risk of pancreatic cancer in people with new-onset diabetes: a Danish nationwide population-based cohort study","volume":"23","author":"Jensen","year":"2023","journal-title":"Pancreatology"},{"key":"B38","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.jss.2008.08.016","article-title":"IGF-1 mediates PTEN suppression and enhances cell invasion and proliferation via activation of the IGF-1\/PI3K\/Akt signaling pathway in pancreatic cancer cells","volume":"160","author":"Ma","year":"2010","journal-title":"J Surg Res"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2019.07.003","article-title":"Endogenous hyperinsulinemia contributes to pancreatic cancer development","volume":"30","author":"Zhang","year":"2019","journal-title":"Cell Metab"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1142\/s0192415x13500444","article-title":"PI3K\/AKT\/mTOR signaling is involved in (-)-epigallocatechin-3-gallate-induced apoptosis of human pancreatic carcinoma cells","volume":"41","author":"Liu","year":"2013","journal-title":"Am J Chin Med"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1002\/jgm.3570","article-title":"Transcriptome data-based status of PI3K\/AKT\/mTOR pathway indicates heterogeneity and immune modulation in patients with pancreatic ductal adenocarcinoma","volume":"26","author":"Xie","year":"2024","journal-title":"J Gene Med"},{"key":"B42","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s40170-022-00282-z","article-title":"Effects of hyperinsulinemia on pancreatic cancer development and the immune microenvironment revealed through single-cell transcriptomics","volume":"10","author":"Zhang","year":"2022","journal-title":"Cancer Metab"},{"key":"B43","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1038\/s41424-018-0008-5","article-title":"Plasma inflammatory cytokines and survival of pancreatic cancer patients","volume":"9","author":"Babic","year":"2018","journal-title":"Clin Transl Gastroenterol"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2011.03.009","article-title":"Stat3\/Socs3 activation by IL-6 transsignaling promotes progression of pancreatic intraepithelial neoplasia and development of pancreatic cancer","volume":"19","author":"Lesina","year":"2011","journal-title":"Cancer Cell"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1152\/ajpendo.2001.280.5.e745","article-title":"Adipose tissue tumor necrosis factor and interleukin-6 expression in human obesity and insulin resistance","volume":"280","author":"Kern","year":"2001","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1038\/s41416-023-02533-2","article-title":"Associations of diabetes, circulating protein biomarkers, and risk of pancreatic cancer","volume":"130","author":"Pang","year":"2024","journal-title":"Br J Cancer"},{"key":"B47","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1158\/2159-8290.cd-13-0593","article-title":"Inflammation-induced NFATc1-STAT3 transcription complex promotes pancreatic cancer initiation by KrasG12D","volume":"4","author":"Baumgart","year":"2014","journal-title":"Cancer Discov"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1172\/jci59743","article-title":"An NF-kappaB pathway-mediated positive feedback loop amplifies Ras activity to pathological levels in mice","volume":"122","author":"Daniluk","year":"2012","journal-title":"J Clin Invest"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1114168109","article-title":"The activity of Gli transcription factors is essential for Kras-induced pancreatic tumorigenesis","volume":"109","author":"Rajurkar","year":"2012","journal-title":"Proc Natl Acad Sci USA"},{"key":"B50","doi-asserted-by":"publisher","first-page":"10","DOI":"10.14341\/2071-8713-5089","article-title":"The global diabetes epidemic as a consequence of lifestyle-induced low-grade inflammation","volume":"53","author":"Kolb","year":"2010","journal-title":"Diabetologia"},{"key":"B51","doi-asserted-by":"publisher","first-page":"49","DOI":"10.4103\/ijmr.ijmr_2238_18","article-title":"Association of inflammatory markers with the disease & mutation status in pancreatic cancer","volume":"155","author":"Singh","year":"2022","journal-title":"Indian J Med Res"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4419-1623-5_62","article-title":"Adrenomedullin is up-regulated in patients with pancreatic cancer and causes insulin resistance in beta cells and mice","volume":"143","author":"Aggarwal","year":"2012","journal-title":"Gastroenterology"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-14-2022","article-title":"Pancreatic cancer-derived exosomes cause paraneoplastic beta-cell dysfunction","volume":"21","author":"Javeed","year":"2015","journal-title":"Clin Cancer Res"},{"key":"B54","doi-asserted-by":"publisher","first-page":"5384","DOI":"10.1038\/s41598-017-05541-4","article-title":"Exosomes derived from pancreatic cancer cells induce insulin resistance in C2C12 myotube cells through the PI3K\/Akt\/FoxO1 pathway","volume":"7","author":"Wang","year":"2017","journal-title":"Sci Rep"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.26508\/lsa.201900573","article-title":"Pancreatic cancer triggers diabetes through TGF-beta-mediated selective depletion of islet beta-cells","volume":"3","author":"Parajuli","year":"2020","journal-title":"Life Sci Alliance"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1007\/s00535-024-02204-w","article-title":"Effect of tumor microenvironment in pancreatic cancer on the loss of beta-cell mass: implications for type 3c diabetes","volume":"60","author":"Hu","year":"2025","journal-title":"J Gastroenterol"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2008.01.039","article-title":"Prevalence and clinical profile of pancreatic cancer-associated diabetes mellitus","volume":"134","author":"Pannala","year":"2008","journal-title":"Gastroenterology"},{"key":"B58","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/jnci\/djy090","article-title":"Pancreatic cancer following incident diabetes in African Americans and Latinos: The Multiethnic Cohort","volume":"111","author":"Setiawan","year":"2019","journal-title":"J Natl Cancer Inst"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1016\/j.gastro.2005.05.007","article-title":"Probability of pancreatic cancer following diabetes: a population-based study","volume":"129","author":"Chari","year":"2005","journal-title":"Gastroenterology"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-011-2316-0","article-title":"Diabetes mellitus, glycated haemoglobin and C-peptide levels in relation to pancreatic cancer risk: a study within the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort","volume":"54","author":"Grote","year":"2011","journal-title":"Diabetologia"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2016.11.046","article-title":"A clinical prediction model to assess risk for pancreatic cancer among patients with new-onset diabetes","volume":"152","author":"Boursi","year":"2017","journal-title":"Gastroenterology"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2018.05.023","article-title":"Model to determine risk of pancreatic cancer in patients with new-onset diabetes","volume":"155","author":"Sharma","year":"2018","journal-title":"Gastroenterology"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djaf308","article-title":"Different diabetes types and pancreatic ductal adenocarcinoma: a mendelian randomization and pathway\/gene-set analysis","volume":"118","author":"Zhang","year":"2026","journal-title":"J Natl Cancer Inst"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph17176016","article-title":"Cohort study of antihyperglycemic medication and pancreatic cancer patients survival","volume":"17","author":"Dulskas","year":"2020","journal-title":"Int J Environ Res Public Health"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1007\/s11605-016-3173-4","article-title":"Metformin use is associated with improved survival in patients undergoing resection for pancreatic cancer","volume":"20","author":"Cerullo","year":"2016","journal-title":"J Gastrointest Surg"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1016\/s1470-2045(15)00027-3","article-title":"Metformin in patients with advanced pancreatic cancer: a double-blind, randomised, placebo-controlled phase 2 trial","volume":"16","author":"Kordes","year":"2015","journal-title":"Lancet Oncol"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-14-814","article-title":"Effects of insulin on human pancreatic cancer progression modeled in vitro","volume":"14","author":"Chan","year":"2014","journal-title":"BMC Cancer"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2013.2720","article-title":"Glucagonlike peptide 1-based therapies and risk of hospitalization for acute pancreatitis in type 2 diabetes mellitus: a population-based matched case-control study","volume":"173","author":"Singh","year":"2013","journal-title":"JAMA Intern Med"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.i581","article-title":"Incretin based drugs and the risk of pancreatic cancer: international multicentre cohort study","volume":"352","author":"Azoulay","year":"2016","journal-title":"BMJ"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djae260","article-title":"Glucagon-like peptide-1 receptor agonists and pancreatic cancer risk: target trial emulation using real-world data","volume":"117","author":"Wang","year":"2025","journal-title":"J Natl Cancer Inst"},{"key":"B71","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1186\/s12933-025-02986-0","article-title":"Risk of all-cause death and pancreatic events following GLP-1 RA initiation in people with obesity or type 2 diabetes: observations from a federated research network","volume":"24","author":"Tartaglia","year":"2025","journal-title":"Cardiovasc Diabetol"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1016\/j.jamcollsurg.2018.12.042","article-title":"Development of diabetes after pancreaticoduodenectomy: Results of a 10-year series using prospective endocrine evaluation","volume":"228","author":"Maxwell","year":"2019","journal-title":"J Am Coll Surg"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgab036","article-title":"Glucose metabolism after pancreatectomy: Opposite extremes between pancreaticoduodenectomy and distal pancreatectomy","volume":"106","author":"Niwano","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-013-3095-2","article-title":"Resolution of new-onset diabetes after radical pancreatic resection predicts long-term survival in patients with pancreatic ductal cell adenocarcinoma","volume":"20","author":"He","year":"2013","journal-title":"Ann Surg Oncol"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgad634","article-title":"High incidence of diabetes mellitus after distal pancreatectomy and its predictors: a long-term follow-up study","volume":"109","author":"Imamura","year":"2024","journal-title":"J Clin Endocrinol Metab"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-015-3522-y","article-title":"Reduction of insulinotropic properties of GLP-1 and GIP after glucocorticoid-induced insulin resistance","volume":"58","author":"Eriksen","year":"2015","journal-title":"Diabetologia"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1056\/nejmoa1009290","article-title":"Everolimus for advanced pancreatic neuroendocrine tumors","volume":"364","author":"Yao","year":"2011","journal-title":"N Engl J Med"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djx012","article-title":"The role of obesity, type 2 diabetes, and metabolic factors in pancreatic cancer: a Mendelian randomization study","volume":"109","author":"Carreras-Torres","year":"2017","journal-title":"J Natl Cancer Inst"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.2337\/db20-0084","article-title":"Is type 2 diabetes causally associated with cancer risk? Evidence from a two-sample mendelian randomization study","volume":"69","author":"Yuan","year":"2020","journal-title":"Diabetes"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2021.11.017","article-title":"Microenvironment drives cell state, plasticity, and drug response in pancreatic cancer","volume":"184","author":"Raghavan","year":"2021","journal-title":"Cell"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2024.03.005","article-title":"Tumor cell-intrinsic epigenetic dysregulation shapes cancer-associated fibroblasts heterogeneity to metabolically support pancreatic cancer","volume":"42","author":"Niu","year":"2024","journal-title":"Cancer Cell"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.2147\/dmso.s430443","article-title":"Pancreatic cancer-derived exosomal miR-Let-7b-5p stimulates insulin resistance in skeletal muscle cells through RNF20\/STAT3\/FOXO1 axis regulation","volume":"16","author":"Wang","year":"2023","journal-title":"Diabetes Metab Syndr Obes"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-025-08917-z","article-title":"Targeting PIKfyve-driven lipid metabolism in pancreatic cancer","volume":"642","author":"Cheng","year":"2025","journal-title":"Nature"},{"key":"B84","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s12943-024-01965-5","article-title":"Activation of the PI3K\/AKT signaling pathway by ARNTL2 enhances cellular glycolysis and sensitizes pancreatic adenocarcinoma to erlotinib","volume":"23","author":"Ge","year":"2024","journal-title":"Mol Cancer"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1097\/mpa.0000000000002419","article-title":"Enhancing pancreatic cancer therapy with targeted CD133-exosome delivery of PD-L1 siRNA: a preclinical investigation","volume":"54","author":"Yoon","year":"2025","journal-title":"Pancreas"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1126\/science.aar3247","article-title":"Detection and localization of surgically resectable cancers with a multi-analyte blood test","volume":"359","author":"Cohen","year":"2018","journal-title":"Science"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1945735\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T04:56:00Z","timestamp":1790744160000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1945735\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,30]]},"references-count":86,"alternative-id":["10.3389\/fendo.2026.1945735"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2026.1945735","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,30]]},"article-number":"1945735"}}